期刊文献+

针刺配合西医治疗抗磷脂酶A2受体抗体阳性中度膜性肾病临床研究 被引量:5

Clinical Study on Acupuncture Combined with Western Medicine for Treating Moderate Membranous Nephropathy with Anti-Phospholipase A_2 Receptor Antibody Positive
在线阅读 下载PDF
导出
摘要 目的观察针刺配合西医治疗抗磷脂酶A_2受体抗体阳性中度膜性肾病患者的临床疗效。方法选择医院肾内科2016年3月至2017年1月收治的抗磷脂酶A_2受体(PLA_2R)抗体阳性的中度膜性肾病患者70例,按照随机数字表法分为对照组和治疗组,各35例。所有患者均给予常规对症治疗,对照组患者加用甲基泼尼松龙和他克莫司,治疗组患者在对照组治疗基础上加用针刺相关穴位。结果治疗后,两组患者的PLA_2R抗体、24 h尿蛋白、血清白蛋白、肾小球滤过率、血小板计数均明显改善,且治疗组显著优于对照组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论针刺配合西医治疗抗磷脂酶A_2受体抗体阳性中度膜性肾病,可显著改善患者的各项生理指标,提高治疗效果。 Objective To observe the clinical effect of acupuncture combined with western medicine for treating moderate membranous nephropathy with anti-phospholipase A2 receptor(PLA2R)antibody positive.Methods Totally 70 patients with moderate membranous nephropathy with anti-PLA2R antibody positive admitted to our hospital from March 2016 to January 2017 were selected and divided into the control group and the treatment group according to the random number method,35 cases in each group.All patients were given conventional symptomatic treatment,the control group was treated with methylprednisolone and tacrolimus,and the treatment group was treated with acupuncture related acupoints on the basis of the control group.Results After treatment,the PLA2R antibody,24 h urinary protein,serum albumin,glomerular filtration rate,platelet count data of the treatment group were significantly improved,and the difference was statistically significant compared with the control group(P<0.05).There was no significant difference in the incidence rate of adverse reactions between the two groups(P>0.05).Conclusion The use of acupuncture combined with western medicine for treating moderate membranous nephropathy with anti-PLA2R antibody positive can significantly improve the patients'physiological indicators and the treatment effect.
作者 李争 贾英辉 杨立豹 康锁彬 赵彦锁 LI Zheng;JIA Ying-hui;YANG Li-bao;KANG Suo-bin;ZHAO Yan-suo(Shijiazhuang Kidney Disease Hospital,Shijiazhuang,Hebei,China 050061)
出处 《中国药业》 CAS 2018年第4期26-28,共3页 China Pharmaceuticals
基金 2016年河北省石家庄市科学技术研究与发展指导计划项目[161462323]
关键词 抗磷脂酶A2受体抗体 膜性肾病 蛋白尿 anti-PLA2R antibody membranous nephropathy acupuncture point proteinuria clinical effect
作者简介 第一作者:李争(1980-),男,大学本科,主治医师,研究方向为肾脏疾病的诊断与治疗,(电子信箱)770516061@qq.com
  • 相关文献

参考文献11

二级参考文献181

  • 1刘春凤,徐元钊,丁小强,傅辰生,张志刚,郭慕依.特发性膜性肾病预后影响因素[J].复旦学报(医学版),2005,32(2):192-196. 被引量:27
  • 2郑丹侠,宋燕,史均宝,韩庆烽,张爱华.原发性膜性肾病85例治疗回顾性纷析[J].临床荟萃,2005,20(20):1145-1147. 被引量:2
  • 3梁世凯,许菲菲,舒桂琴,吕吟秋,邵蓉蓉,刘毅.70例特发性膜性肾病的临床特点和治疗探讨[J].中国中西医结合肾病杂志,2006,7(10):595-597. 被引量:9
  • 4Shiiki H,Saito T,Nishitani Y,et al. Prognosis and risk factorsfor idiopathic membranous nephropathy with nephroticsyndrome in Japan[J]. Kidney Int,2004,65(4) : 1400-1407.
  • 5Ponticelli C,Altieri P, Scolari F,et al. A randomized studycomparing methylprednisolone plus chlorambucil versusmethylprednisolone plus cyclo-phosphamide in idiopathicmembranous nephropathy[J]. J Am Soc Nephrol,1998,9(3):444-450.
  • 6Jha V,Ganguli A,Saha TK,et al. A randomized controlled trialof steroids and cyclophosphamide in adults with nephroticsyndrome caused by idiopathic membranous nephropathy[J], JAm Soc Nephrol,2007,18(6) :1899-1904.
  • 7Yuan J . Fang W, Zhang W, et al. Treatment of nephroticidiopathic membranous nephropathy with monthly i. v. pulsecyclophosphamide and oral steroids: a single center, sretrospective study [J]. Nephrology ( Carlton ),2011,16(4):440-445.
  • 8Quaglia M, Stratta P. Idiopathic membranous nephropathymanagement strategies[J], Drugs,2009,69( 10) : 1303-1317.
  • 9Ponticelli C,Zucchelli P, Passerini P. Therapy of idiopathicmembranous nephropathy[J]. Springer Semin Immunopathol,1987,9(4):431-440.
  • 10Braden GL, Mulhern JG, O'Shea MH, et al. Changing incidence of glomerular diseases in adults[J]. Am J Kidney Dis, 2000, 35 (5): 878 -883.

共引文献149

同被引文献99

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部